241 related articles for article (PubMed ID: 17487372)
1. Effects of leptin on human breast cancer cell lines in relationship to estrogen receptor and HER2 status.
Ray A; Nkhata KJ; Cleary MP
Int J Oncol; 2007 Jun; 30(6):1499-509. PubMed ID: 17487372
[TBL] [Abstract][Full Text] [Related]
2. Synergy of leptin/STAT3 with HER2 receptor induces tamoxifen resistance in breast cancer cells through regulation of apoptosis-related genes.
Papanikolaou V; Stefanou N; Dubos S; Papathanasiou I; Palianopoulou M; Valiakou V; Tsezou A
Cell Oncol (Dordr); 2015 Apr; 38(2):155-64. PubMed ID: 25539992
[TBL] [Abstract][Full Text] [Related]
3. Effects of adiponectin and leptin co-treatment on human breast cancer cell growth.
Nkhata KJ; Ray A; Schuster TF; Grossmann ME; Cleary MP
Oncol Rep; 2009 Jun; 21(6):1611-9. PubMed ID: 19424644
[TBL] [Abstract][Full Text] [Related]
4. Diet-induced obesity and mammary tumor development in relation to estrogen receptor status.
Ray A; Nkhata KJ; Grande JP; Cleary MP
Cancer Lett; 2007 Aug; 253(2):291-300. PubMed ID: 17399892
[TBL] [Abstract][Full Text] [Related]
5. Leptin induces functional activation of cyclooxygenase-2 through JAK2/STAT3, MAPK/ERK, and PI3K/AKT pathways in human endometrial cancer cells.
Gao J; Tian J; Lv Y; Shi F; Kong F; Shi H; Zhao L
Cancer Sci; 2009 Mar; 100(3):389-95. PubMed ID: 19154413
[TBL] [Abstract][Full Text] [Related]
6. Obesity Suppresses Estrogen Receptor Beta Expression in Breast Cancer Cells via a HER2-Mediated Pathway.
Bowers LW; Wiese M; Brenner AJ; Rossi EL; Tekmal RR; Hursting SD; deGraffenried LA
PLoS One; 2015; 10(12):e0145452. PubMed ID: 26709918
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of phenethyl isothiocyanate in HER2-positive breast cancer models.
Gupta P; Srivastava SK
BMC Med; 2012 Jul; 10():80. PubMed ID: 22824293
[TBL] [Abstract][Full Text] [Related]
8. Leptin attenuates the anti-estrogen effect of tamoxifen in breast cancer.
Chen X; Zha X; Chen W; Zhu T; Qiu J; Røe OD; Li J; Wang Z; Yin Y
Biomed Pharmacother; 2013 Feb; 67(1):22-30. PubMed ID: 23199901
[TBL] [Abstract][Full Text] [Related]
9. Leptin--a growth factor in normal and malignant breast cells and for normal mammary gland development.
Hu X; Juneja SC; Maihle NJ; Cleary MP
J Natl Cancer Inst; 2002 Nov; 94(22):1704-11. PubMed ID: 12441326
[TBL] [Abstract][Full Text] [Related]
10. Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-alpha and survivin.
Vanderlaag KE; Hudak S; Bald L; Fayadat-Dilman L; Sathe M; Grein J; Janatpour MJ
Breast Cancer Res; 2010; 12(3):R32. PubMed ID: 20525379
[TBL] [Abstract][Full Text] [Related]
11. Obesity associated alterations in the biology of adipose stem cells mediate enhanced tumorigenesis by estrogen dependent pathways.
Strong AL; Strong TA; Rhodes LV; Semon JA; Zhang X; Shi Z; Zhang S; Gimble JM; Burow ME; Bunnell BA
Breast Cancer Res; 2013; 15(5):R102. PubMed ID: 24176089
[TBL] [Abstract][Full Text] [Related]
12. Leptin induces a proliferative response in breast cancer cells but not in normal breast cells.
Dubois V; Jardé T; Delort L; Billard H; Bernard-Gallon D; Berger E; Geloen A; Vasson MP; Caldefie-Chezet F
Nutr Cancer; 2014; 66(4):645-55. PubMed ID: 24738610
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: possible role of obesity-related stimuli.
Garofalo C; Koda M; Cascio S; Sulkowska M; Kanczuga-Koda L; Golaszewska J; Russo A; Sulkowski S; Surmacz E
Clin Cancer Res; 2006 Mar; 12(5):1447-53. PubMed ID: 16533767
[TBL] [Abstract][Full Text] [Related]
14. Benzyl isothiocyanate inhibits oncogenic actions of leptin in human breast cancer cells by suppressing activation of signal transducer and activator of transcription 3.
Kim SH; Nagalingam A; Saxena NK; Singh SV; Sharma D
Carcinogenesis; 2011 Mar; 32(3):359-67. PubMed ID: 21163886
[TBL] [Abstract][Full Text] [Related]
15. Fenhexamid induces cancer growth and survival via estrogen receptor-dependent and PI3K-dependent pathways in breast cancer models.
Go RE; Kim CW; Lee SM; Lee HK; Choi KC
Food Chem Toxicol; 2021 Mar; 149():112000. PubMed ID: 33484789
[TBL] [Abstract][Full Text] [Related]
16. Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor-negative breast cancer via Src family kinase-mediated, janus kinase 2-independent pathway.
Alshaker H; Krell J; Frampton AE; Waxman J; Blyuss O; Zaikin A; Winkler M; Stebbing J; Yagüe E; Pchejetski D
Breast Cancer Res; 2014 Oct; 16(5):426. PubMed ID: 25482303
[TBL] [Abstract][Full Text] [Related]
17. Leptin-signaling inhibition results in efficient anti-tumor activity in estrogen receptor positive or negative breast cancer.
Rene Gonzalez R; Watters A; Xu Y; Singh UP; Mann DR; Rueda BR; Penichet ML
Breast Cancer Res; 2009; 11(3):R36. PubMed ID: 19531256
[TBL] [Abstract][Full Text] [Related]
18. Cellular and molecular crosstalk between leptin receptor and estrogen receptor-{alpha} in breast cancer: molecular basis for a novel therapeutic setting.
Fusco R; Galgani M; Procaccini C; Franco R; Pirozzi G; Fucci L; Laccetti P; Matarese G
Endocr Relat Cancer; 2010 Jun; 17(2):373-82. PubMed ID: 20410173
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of mild hyperthermia plus docetaxel therapy on ER(+/-) breast cancer cells and action mechanisms.
Lv F; Yu Y; Zhang B; Liang D; Li ZM; You W
J Huazhong Univ Sci Technolog Med Sci; 2013 Dec; 33(6):870-876. PubMed ID: 24337851
[TBL] [Abstract][Full Text] [Related]
20. leptin-induced growth stimulation of breast cancer cells involves recruitment of histone acetyltransferases and mediator complex to CYCLIN D1 promoter via activation of Stat3.
Saxena NK; Vertino PM; Anania FA; Sharma D
J Biol Chem; 2007 May; 282(18):13316-25. PubMed ID: 17344214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
